Prestige Wealth Management Group’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$584 Hold
49
﹤0.01% 944
2025
Q4
$489 Hold
49
﹤0.01% 955
2025
Q3
$439 Hold
49
﹤0.01% 947
2025
Q2
$463 Hold
49
﹤0.01% 940
2025
Q1
$532 Hold
49
﹤0.01% 924
2024
Q4
$467 Hold
49
﹤0.01% 974
2024
Q3
$551 Hold
49
﹤0.01% 949
2024
Q2
$490 Hold
49
﹤0.01% 924
2024
Q1
$564 Buy
+49
New +$416 ﹤0.01% 939
2023
Q4
Sell
-30
Closed -$273 1024
2023
Q3
$273 Buy
+30
New +$360 ﹤0.01% 1016
2023
Q1
Sell
-200
Closed -$3.84K 1055
2022
Q4
$3.84K Hold
200
﹤0.01% 674
2022
Q3
$4K Buy
+200
New +$4.11K ﹤0.01% 574

Other funds holding AHCO

Prestige Wealth Management Group's AHCO Position: Q1 2026 in Review

Prestige Wealth Management Group held its AdaptHealth (AHCO) position steady in Q1 2026 at 49 shares worth $584. The position accounts for ﹤0.01% of the portfolio, ranked #944.

Prestige Wealth Management Group first reported a position in AHCO in Q3 2022 and has held it in 12 quarters since. The position peaked at $4K in Q3 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Prestige Wealth Management Group held 49 shares of AdaptHealth worth $584 as of Q1 2026.
  • Prestige Wealth Management Group left its AdaptHealth share count unchanged in Q1 2026.
  • AdaptHealth made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q1 2026, its #944 holding.
  • Prestige Wealth Management Group first reported a position in AdaptHealth in Q3 2022 and has held it in 12 quarters since.
  • Prestige Wealth Management Group's AdaptHealth position peaked at $4K in Q3 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Prestige Wealth Management Group's 13F filing for Q1 2026, filed 13 May 2026.